Cochlear Limited (ASX:COH)
141.27
+1.45 (1.04%)
Oct 28, 2026, 10:29 AM AEDT
Cochlear Revenue
In the fiscal year ending June 30, 2026, Cochlear had annual revenue of 2.35B AUD with 0.19% growth. Cochlear had revenue of 1.18B in the half year ending June 30, 2026, with 3.81% growth. That makes Cochlear the 5,644th largest company in the world by revenue and 96th in Australia.
Revenue
2.35B
Revenue Growth
+0.19%
P/S Ratio
3.90
Revenue / Employee
434.74K
Employees
5,400
Market Cap
9.24B
Revenue by Segment
Fiscal year ended Jun 30, 2026 See the full Cochlear breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 2.35B | 4.50M | 0.19% |
| Jun 30, 2025 | 2.34B | 107.50M | 4.81% |
| Jun 30, 2024 | 2.24B | 299.50M | 15.47% |
| Jun 30, 2023 | 1.94B | 287.80M | 17.46% |
| Jun 30, 2022 | 1.65B | 150.70M | 10.06% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PolyNovo | 149.85M |
| Saluda Medical | 130.35M |
| SomnoMed | 114.53M |
| Aroa Biosurgery | 86.47M |
| Cyclopharm | 34.42M |
| Lumos Diagnostics Holdings | 19.07M |
| EBR Systems | 9.32M |
| EMVision Medical Devices | 8.36M |
Cochlear News
- 2 days ago - Cochlear Transcript: AGM 2026 - Transcripts
- 7 days ago - Cochlear® Nucleus® Nexa® System Named One of TIME's Best Inventions of 2026 - PRNewsWire
- 7 days ago - Cochlear Shares Climb 5.4% as Hearing Implant Giant Attempts Comeback After Brutal 2026 Earnings Shock - International Business Times (Australia)
- 4 weeks ago - Cochlear to defend shareholder class action over 2026 profit forecast - Reuters
- 4 weeks ago - Cochlear Reaches More Than 1 Million Hours of Patient Experience Across Its Fully Implantable Hearing Technology Research Program - Business Wire
- 2 months ago - Cochlear Earnings Call Transcript: H2 2026 - Transcripts
- 2 months ago - Cochlear Annual report: H2 2026 - Filings
- 2 months ago - Cochlear Earnings release: H2 2026 - Filings